SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-018099
Filing Date
2019-10-08
Accepted
2019-10-08 08:00:39
Documents
15
Period of Report
2019-10-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8k.htm   iXBRL 8-K 40061
2 PRESS RELEASE OF BRISTOL-MYERS SQUIBB COMPANY ex99_1.htm EX-99.1 75719
7 image00001.jpg GRAPHIC 3188
  Complete submission text file 0001140361-19-018099.txt   317090

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmy-20191008.xsd EX-101.SCH 4985
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20191008_def.xml EX-101.DEF 18665
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20191008_lab.xml EX-101.LAB 28806
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20191008_pre.xml EX-101.PRE 20965
12 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 7261
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 191141815
SIC: 2834 Pharmaceutical Preparations